The law firm of Finkelstein Thompson LLP is investigating potential
claims on behalf of shareholders of Tellabs Inc. (Nasdaq: TLAB)
(“Tellabs” or “the Company”), concerning the Company’s proposed
acquisition by Marlin Equity Partners. Under the terms of the merger
agreement, Tellabs’ common shareholders will receive $2.45 in cash for
each common share of Tellabs stock they own. At least one analyst has
set a target price of $2.50 for Tellabs shares. The total deal is valued
at approximately $891 million.
The investigation is focused on whether Tellabs’ Board of Directors
breached its fiduciary duty in failing to maximize consideration to
shareholders, the potential unfairness of the consideration to
shareholders, the process by which the Board considered the transaction,
and potential conflicts of interest among the Company’s Board members.
If you are interested in discussing your rights as a Tellabs
shareholder, or have information relating to this investigation, please
contact Finkelstein Thompson’s Washington, DC offices at (877) 337-1050
or (202) 337-8000, or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering
outstanding representation to institutional and individual clients in
financial litigation, and has been appointed as lead or co-counsel in
dozens of shareholder class actions. Indeed, the firm has served in
leadership roles in cases that have recovered over $1 billion for
investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website
at www.finkelsteinthompson.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Copyright Business Wire 2013